Carcinoma,%20Renal%20Cell
Showing 9976 - 10000 of >10,000
Tumors Trial in France (Blood and tumor samples)
Recruiting
- Neoplasms
- Blood and tumor samples
-
Annecy, France
- +5 more
Apr 8, 2022
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)
Not yet recruiting
- T-cell Lymphoma
- +10 more
-
Chicago, IllinoisRush University Medical Center
Oct 24, 2022
Hepatocellular Carcinoma Trial in Toronto (Pembrolizumab, Stereotactic Body Radiotherapy (SBRT))
Recruiting
- Hepatocellular Carcinoma
- Pembrolizumab
- Stereotactic Body Radiotherapy (SBRT)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Dec 31, 2021
Advanced Solid Tumor Trial in Hangzhou (KN052)
Recruiting
- Advanced Solid Tumor
- KN052
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 16, 2022
Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2023
Pravastatin on Renal Function in Korean Dyslipidemic Type 2
Completed
- Dyslipidemia Associated With Type II Diabetes Mellitus
-
Ansan, Korea, Republic of
- +46 more
Oct 27, 2021
Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)
Not yet recruiting
- Hematopoietic Stem Cell Transplant
- Cardio-oncology program
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 6, 2023
Malignant Pleural Effusion Trial in Chandigarh (Doxycycline, Iodopovidine)
Active, not recruiting
- Malignant Pleural Effusion
- Doxycycline
- Iodopovidine
-
Chandigarh, IndiaBronchoscopy suite, PGIMER
Mar 20, 2021
Response and Resistance to Pembrolizumab in Melanoma
Recruiting
- Melanoma
- Advanced Melanoma
- Biopsy
- Biospecimen Collection
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 17, 2022
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
Sickle Cell Disease, Chronic Pain Trial (Quantitative sensory testing)
Not yet recruiting
- Sickle Cell Disease
- Chronic Pain
- Quantitative sensory testing
- (no location specified)
Nov 15, 2023
Hepatocellular Carcinoma Non-resectable Trial in France (Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
-
Bordeaux, France
- +5 more
Jun 12, 2023
End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)
Completed
- End Stage Renal Disease Requiring Hemodialysis
- BAY2976217
- Placebo
-
Clovis, California
- +68 more
Jan 20, 2023
End Stage Renal Disease Trial in Indianapolis (VFI using the FAST PV Technology)
Completed
- End Stage Renal Disease
- VFI using the FAST PV Technology
-
Indianapolis, IndianaRichard L. Roudebush VA Medical Center
Mar 7, 2022
Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,
Recruiting
- Hand, Foot and Mouth Disease
- Herpangina
- low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
- +3 more
-
Chuxiong, Yunnan, ChinaDayao County Center for Disease Control and Prevention
Sep 25, 2023
B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- CB dualCAR-NK19/70
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 25, 2022
Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib, Polatuzumab Vedotin, Rituximab
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 10, 2023
Acute Lymphoblastic Leukemia, Non Hodgkin Lymphoma Trial (CD19-UCART)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Non Hodgkin Lymphoma
- CD19-UCART
- (no location specified)
Jan 25, 2023
Volume Overload Trial in Cleveland (Oral Sodium Chloride, Placebo)
Active, not recruiting
- Volume Overload
- Oral Sodium Chloride
- Placebo
-
Cleveland, OhioCleveland Clinic
Oct 1, 2022
Differentiated Thyroid Cancer Trial (Low iodine diet)
Not yet recruiting
- Differentiated Thyroid Cancer
- Low iodine diet
- (no location specified)
Oct 25, 2022
Renal Anemia in Non-dialysis Chronic Kidney Disease Trial in Guangzhou (SAL-0951, Placebo)
Completed
- Renal Anemia in Non-dialysis Chronic Kidney Disease
- SAL-0951
- Placebo
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 23, 2023
Extensive Small Cell Lung Cancer Trial in China (TQB2450, Anlotinib, Etoposide)
Not yet recruiting
- Extensive Small Cell Lung Cancer
- TQB2450
- +5 more
-
Bengbu, Anhui, China
- +25 more
Jan 18, 2020